Resources from the same session
2MO - EO2401 (EO) therapeutic vaccine for patients (pts) with adrenocortical carcinoma (ACC) and malignant pheochromocytoma/paraganglioma (MPP): Phase I/II SPENCER study
Presenter: Eric Baudin
Session: Mini Oral session: NETs and endocrine tumours
Resources:
Abstract
Slides
Webcast